Vibrant Therapeutics
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $61M
Overview
A biotech company creating innovative cancer vaccines to induce potent anti-tumor immune responses.
OncologyVaccinesImmunology
Technology Platform
A platform for designing and delivering cancer vaccines, potentially using viral vectors or nucleic acids, aimed at generating strong and specific T-cell immunity against tumors.
Funding History
1Total raised:$61M
PIPE$61M
Opportunities
A successful cancer vaccine, especially if off-the-shelf, could become a foundational component of combination immunotherapy regimens across many cancers.
Risk Factors
The historical difficulty of demonstrating clear clinical efficacy for cancer vaccines and the high cost/complexity of personalized approaches are major hurdles.
Competitive Landscape
Competes in the active cancer vaccine sector with large mRNA players and specialized biotechs, requiring strong data to differentiate its approach.